Malignant neoplasm of frontal lobe
ICD-10 C71.1 is a billable code used to indicate a diagnosis of malignant neoplasm of frontal lobe.
C71.1 refers to a malignant neoplasm located in the frontal lobe of the brain, which is a critical area responsible for various higher cognitive functions, including reasoning, problem-solving, and emotional regulation. These tumors can arise from glial cells (gliomas), meningeal tissue (meningiomas), or can be metastatic from other primary cancers. Symptoms may include changes in personality, cognitive decline, seizures, and motor deficits, depending on the tumor's size and location. Imaging studies, particularly MRI, are essential for diagnosis, revealing the tumor's size, location, and effect on surrounding brain structures. Molecular markers, such as IDH1/2 mutations and 1p/19q co-deletion status, can provide prognostic information and guide treatment decisions. Treatment typically involves a multidisciplinary approach, including surgical resection, radiation therapy, and chemotherapy, tailored to the tumor's characteristics and the patient's overall health.
Detailed operative reports, imaging studies, and pathology results.
Surgical resection of frontal lobe tumors, management of post-operative complications.
Ensure accurate coding of tumor type and extent of resection.
Comprehensive treatment plans, including chemotherapy and radiation therapy details.
Management of malignant brain tumors, including adjuvant therapies.
Document molecular markers and treatment response for accurate coding.
Used during surgical resection of a frontal lobe tumor.
Operative report detailing the procedure and findings.
Neurosurgeons must document tumor type and extent of resection.
MRI is the preferred imaging modality for diagnosing and assessing malignant neoplasms of the frontal lobe, providing detailed information about tumor size, location, and effects on surrounding structures.
